SCHEMBL13870588

SCHEMBL13870588

C=Nc1c(C(=O)OCC)nn(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.66
CYP3A4 P08684 2/20 0.66
CYP2C9 P11712 2/20 0.66
CYP2C19 P33261 2/20 0.66
NPSR1 Q6W5P4 4/20 0.57
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
KDM4E B2RXH2 4/20 0.55
HSD17B10 Q99714 2/20 0.55
HPGD P15428 1/20 0.55
ALOX12 P18054 2/20 0.52
TP53 P04637 1/20 0.52
CYP19A1 P11511 1/20 0.50
PDE4D Q08499 1/20 0.49
HTT P42858 1/20 0.48
MAPT P10636 3/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
APP P05067 1/20 0.47
GABRA2 P47869 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2919412 0.84 ALDH1A1 (0.73) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL13870585 0.82 CYP2C9 (0.49) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL13870586 0.82 CYP2C9 (0.51) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL2918809 0.81 ALDH1A1 (0.70) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL14369638 0.79 KDM4E (0.68) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL18353617 0.77 ALDH1A1 (0.64) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL10563617 0.77 ALDH1A1 (0.58) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL29838942 0.76 ALDH1A1 (0.63) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL12266478 0.76 PDE4D (0.73) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL20142756 0.75 ALDH1A1 (0.71) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7521471-B2 4-cyanopyrazole-3-carboxamide derivatives, preparation and application thereof SANOFI-AVENTIS (FR) 2009-04-21 US disclosed
US-20070293541-A1 4-CYANOPYRAZOLE-3-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF SANOFI-AVENTIS (FR) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293541-A1 4-CYANOPYRAZOLE-3-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF CBR3, CNR1, CNR2 ALDH1A1 742/4885CYP3A4 87/4885CYP2C9 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.